Placenta-Specific miR-125b Overexpression Leads to Increased Rates of Pregnancy Loss in Mice.
Fen SunHui CaiLunbo TanDezhe QinJian ZhangJinlian HuaXiujun FanSha PengPublished in: International journal of molecular sciences (2022)
Pregnancy loss (PL) is one of the common complications that women can experience during pregnancy, with an occurrence rate of 1 to 5%. The potential causes of pregnancy loss are unclear, with no effective treatment modalities being available. It has been previously reported that the level of miR-125b was significantly increased in placentas of PL patients. However, the role of miR-125b in the development of PL still remains unknown. In the current study, an miR-125b placenta-specific over-expression model was constructed by lentiviral transfecting zona-free mouse embryos followed by embryo transfer. On gestation day 15, it was observed that the placenta was significantly smaller in the miR-125b placenta-specific overexpression group than the control group. Additionally, the abortion rate of the miR-125b placenta-specific overexpression group was markedly higher than in the control group. The blood vessel diameter was larger in the miR-125b-overexpressing specific placenta. In addition, miR-125b-overexpressing HTR8 and JEG3 cell lines were also generated to analyze the migration and invasion ability of trophoblasts. The results showed that miR-125b overexpression significantly suppressed the migration and invasion ability of HTR8 and JEG3 cells. Overall, our results demonstrated that miR-125b can affect embryo implantation through modulating placenta angiogenesis and trophoblast cell invasion capacity that can lead to PL.
Keyphrases
- cell proliferation
- pregnancy outcomes
- end stage renal disease
- transcription factor
- induced apoptosis
- risk assessment
- chronic kidney disease
- preterm infants
- prognostic factors
- poor prognosis
- endothelial cells
- newly diagnosed
- pregnant women
- oxidative stress
- binding protein
- skeletal muscle
- risk factors
- endoplasmic reticulum stress
- high fat diet induced
- replacement therapy
- patient reported
- gene therapy